Copied
 
 
Formål
Formål
Selskabets formål er udvikling, fabrikation og salg af lægemidler og andre produkter til helse- og sundhedspleje samt kemisk-tekniske artikler, at drive medicinsk-teknisk virksomhed og anden dermed forbunden virksomhed samt at eje og forvalte fast ejendom og løsøre.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 15.04.2009 (5497 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 12.09.2022 og angivet som gældende fra 12.09.2022 (599 dage).
HistorikStartStop
NORMAL12.09.2022
UNDER TVANGSOPLØSNING24.08.202211.09.2022
NORMAL24.11.200423.08.2022
Branche
Branche
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000).
Sidst opdateret den 24.12.2007 og angivet som gældende fra 01.01.2008 (5967 dage).
HistorikStartStop
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000)01.01.2008
Medicinalvarefabrikker (244200)11.04.200531.12.2007
Uoplyst (980000)24.11.200410.04.2005
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 24.11.2004 (7100 dage).
Ingen historik.
Revisor
Revisor
GRANT THORNTON,STATSAUTORISERET REVISIONSPARTNERSELSKAB
Sidst opdateret den 12.09.2022 og angivet som gældende fra 30.08.2022 (612 dage).
Form
Virksomhedsform
60.
Sidst opdateret den 11.01.2005 og angivet som gældende fra 24.11.2004 (7100 dage).
Ingen historik.
Kontakt
Ingen nuværende registrering.
Ingen historik.
Telefon
Telefonnummer
39404846.
Sidst opdateret den 21.11.2018 og angivet som gældende fra 21.11.2018 (1990 dage).
HistorikStartStop
3940484621.11.2018
3940422516.12.200420.11.2018
Navne
Ingen historik.
Tegningsregel
Tegningsregel
Selskabet tegnes af to bestyrelsesmedlemmer i forening.
Sidst opdateret den 12.09.2022 og angivet som gældende fra 30.08.2022 (612 dage).
Fortolkning (1 tegningsmulighed)
2 bestyrelsesmedlemmer +
HistorikStartStop
Selskabet tegnes af to bestyrelsesmedlemmer i forening30.08.2022
Selskabet tegnes af to bestyrelsesmedlemmer i forening15.04.200922.08.2022
Ansatte
03.05.2024
Kapital
03.05.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Grant Thornton, statsautoriseret revisionspartnerselskab,
Revisionsvirksomhedens CVR-nr.:34209936
Beskrivelse af revisor:statsautoriseret revisor
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis for Opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Nobel Biocare Danmark A/S for the financial year 1 January - 31 December 2022, which comprise income statement, balance sheet, statement of changes in equity, notes and a summary of significant accounting policies, for the Company. The financial statements are prepared under the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2022, and of the results of the Company's operations for the financial year 1 January - 31 December 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Review Management is responsible for Management’s Review. Our opinion on the financial statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that Management’s Review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of Management’s Review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
03.05.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
03.05.2024
Ingen nuværende registrering.
Ingen historik.